AULSF.US Austar Lifesciences Limited
- Market cap
- USD 10.3M
- P/E
- 2.0x
- P/B
- 0.08x
- ROE
- 4.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is AULSF.US undervalued?
Graham numberThe Graham number of Austar Lifesciences Limited cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Austar Lifesciences Limited fundamental analysis
No fundamental analysis for Austar Lifesciences Limited yet.
Austar Lifesciences Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Austar Lifesciences Limited
Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. The company also offers clean utility equipment and chemical pharmaceutical preparation syst…
Full company profileAustar Lifesciences Limited financial statements
Austar Lifesciences Limited annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.30B | 2.02B | 2.16B | 1.76B | 1.50B | 1.53B |
| Gross Profit | 324M | 479M | 489M | 336M | 301M | 293M |
| Operating Income | 35.5M | 121M | 123M | -9.01M | 36.1M | 33.7M |
| EBITDA | - | - | 166M | 25.3M | 91.5M | 109M |
| Net Income | 33.1M | 277M | 87.5M | -113M | 16.1M | 33.8M |
| EPS | 0.06 | 0.54 | 0.17 | -0.22 | 0.03 | 0.07 |
| Balance Sheet | ||||||
| Total Assets | 1.38B | 2.04B | 2.39B | 2.16B | 2.08B | 2.13B |
| Total Liabilities | 854M | 1.26B | 1.51B | 1.38B | 1.29B | 1.30B |
| Shareholders' Equity | 525M | 788M | 884M | 775M | 791M | 823M |
| Cash & Short-term Investments | 178M | 198M | 134M | 164M | 167M | 227M |
| Cash Flow | ||||||
| Operating Cash Flow | 52.2M | -103M | -37.9M | -62.6M | 98.8M | 132M |
| Capital Expenditure | 67.2M | 116M | 136M | 70.9M | 23.1M | 29.7M |
| Free Cash Flow | -15.0M | -219M | -174M | -134M | 75.7M | 102M |
| Ratios | ||||||
| ROE | 6.3% | 35.2% | 9.9% | -14.6% | 2.0% | 4.1% |
| ROA | 2.4% | 13.6% | 3.7% | -5.3% | 0.8% | 1.6% |
| Net Profit Margin | 2.6% | 13.8% | 4.1% | -6.4% | 1.1% | 2.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Austar Lifesciences Limited dividends
Austar Lifesciences Limited has not paid dividends in the last 6 fiscal years.
Who owns Austar Lifesciences Limited
- Insiders 73.54%
- Institutions 0.00%
- Public & others 26.46%
- Shares outstanding 513M
- Free float 136M
Austar Lifesciences Limited company profile
- Company name
- Austar Lifesciences Limited
- Ticker
- AULSF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 1,490
- Fiscal year end
- December
- Address
- No. 1018, Changning Road, Shanghai, China
- Phone
- 86 40 0812 1586
- Website
- austar.com.hk
About Austar Lifesciences Limited
Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. The company also offers clean utility equipment and chemical pharmaceutical preparation systems; bioprocess equipment and systems; clean room, automation control, and monitoring systems; powder and solid equipment and systems; aseptic freeze-drying, filling, and visual inspection solutions; pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; and laboratory one-stop solutions. In addition, it provides consulting and engineering technical services; compliance and validation services; digital factory services; clean room HVAC/EMS/BMS services; and upgrade, retrofit, and maintenance services. Further, it engages in life science consumables, advanced therapies, and advanced bioprocessing technologies, as well as engineering design services. Austar Lifesciences Limited was founded in 1991 and is headquartered in Shanghai, China.
Austar Lifesciences Limited management
7- Mr. Kwok Keung HoFounder, Chairman of the Board & CEO · born 1962
- Madam Ning ZhouExecutive Director · born 1973
- Mr. Kin Hung HoExecutive Director · born 1957
- Mr. Ce BianExecutive Director · born 1977
- Madam Xiangdi TangVice President of Corporate Development & Finance · born 1978
- Madam Wang WeiSenior Vice President · born 1974
- Ms. Yuk Kiu MakCompany Secretary